{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T18:54:28Z","timestamp":1725648868118},"reference-count":8,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.leukres.2012.09.006","type":"journal-article","created":{"date-parts":[[2012,9,29]],"date-time":"2012-09-29T19:48:37Z","timestamp":1348948117000},"page":"1498-1499","source":"Crossref","is-referenced-by-count":3,"title":["Can we safely discontinue imatinib? Searching for new endpoints in CML: A standardized definition of \u201ccure\u201d"],"prefix":"10.1016","volume":"36","author":[{"given":"Massimo","family":"Breccia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Alimena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2012.09.006_bib0005","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2011-08-376087","article-title":"Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)","volume":"119","author":"Kantarjian","year":"2012","journal-title":"Blood"},{"issue":"May","key":"10.1016\/j.leukres.2012.09.006_bib0010","article-title":"Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up","author":"Larson","year":"2012","journal-title":"Leukemia"},{"issue":"April","key":"10.1016\/j.leukres.2012.09.006_bib0015","article-title":"Standardized definitions of molecular response in chronic myeloid leukemia","author":"Cross","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.09.006_bib0020","first-page":"632","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukemia who have maintained complete molecular remission: update results of the STIM study","volume":"114","author":"Mahon","year":"2011","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2012.09.006_bib0025","first-page":"0189","article-title":"Frequent and sustained drug-free remission in the Australasian CML8 trial of imatinib withdrawal","volume":"97","author":"Ross","year":"2012","journal-title":"Haematologica"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2012.09.006_bib0030","first-page":"0194","article-title":"Loss of major molecular response is accurate for restarting imatinib after imatinib discontinuation in CP-CML patients with long lasting CMR: importance of fluctuating values of MRD and interferon","volume":"97","author":"Rousselot","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2012.09.006_bib0035","first-page":"608","article-title":"Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia (CML) patients (pts) with stable undetectable Bcr-Aabl transcripts: results from the French CML group (FILMC)","volume":"114","author":"Rea","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.09.006_bib0040","first-page":"632","volume":"114","author":"Giles","year":"2011","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612003785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612003785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T06:57:22Z","timestamp":1542697042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212612003785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0145212612003785"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2012.09.006","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}